Driving Progress in AML
Dr. David Sallman from Moffitt Cancer Center discusses recent advances in acute myeloid leukemia (AML). The conversation covers newly approved therapies, such as menin inhibitors, and investigational approaches in clinical trials, and their impact on treatment decisions and…